aravive.com | Home

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
# Default Flywheel robots file User-agent: * Disallow: /calendar/action:posterboard/ Disallow: /calendar/action:agenda/ Disallow: /calendar/action:oneday/ Disallow: /calendar/action:month/ Disallow: /calendar/action:week/ Disallow: /calendar/action:map/ Disallow: /calendar/action~posterboard/ Disallow: /calendar/action~agenda/ Disallow: /calendar/action~oneday/ Disallow: /calendar/action~month/ Disallow: /calendar/action~week/ Disallow: /calendar/action~stream/ Disallow: /events/action~posterboard/ Disallow: /events/action~agenda/ Disallow: /events/action~oneday/ Disallow: /events/action~month/ Disallow: /events/action~week/ Disallow:

Meta Tags

Title	Home \| Aravive,
Description	Developing Transformative Targeted Cancer News Careers Who We Are Our Science Pipeline Patient & Caregiver Resources Investors Contact Menu Developing Transformative Targeted Cancer therapeutics D
Keywords	N/A

Server Information

WebSite	aravive.com
Host IP	104.196.57.55
Location	United States

Related Websites

                        Site
                        Rank
                    

More to Explore

arenaofgowrivakkam.com

armoured-solutions.com

ascentconstructions.com

ascentmmi.com

aseanta.org

aravive.com Valuation

US$9,944,710

Last updated: 2023-05-08 21:45:59

aravive.com has Semrush global rank of 1,064,315. aravive.com has an estimated worth of US$ 9,944,710, based on its estimated Ads revenue. aravive.com receives approximately 1,147,467 unique visitors each day. Its web server is located in United States, with IP address 104.196.57.55. According to SiteAdvisor, aravive.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$9,944,710
Daily Ads Revenue	US$9,180
Monthly Ads Revenue	US$275,392
Yearly Ads Revenue	US$3,304,704
Daily Unique Visitors	76,498
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
aravive.com.	A	599	IP: 104.196.57.55
aravive.com.	NS	3600	NS Record: ns51.domaincontrol.com.
aravive.com.	NS	3600	NS Record: ns52.domaincontrol.com.
aravive.com.	MX	3600	MX Record: 0 us-smtp-inbound-1.mimecast.com.
aravive.com.	MX	3600	MX Record: 0 us-smtp-inbound-2.mimecast.com.
aravive.com.	TXT	3600	TXT Record: MS=ms81898674
aravive.com.	TXT	3600	TXT Record: v=spf1 include:_netblocks.mimecast.com ~all
aravive.com.	TXT	3600	TXT Record: ZOOM_verify_jpWqIlpjQvmhKld7f6AYFg
aravive.com.	TXT	3600	TXT Record: 0ed1fe018a72179963571e42638f20ce736b224827

HtmlToTextCheckTime:2023-05-08 21:45:59

News Careers Who We Are Our Science Pipeline Patient & Caregiver Resources Investors Contact Menu Developing Transformative Targeted Cancer therapeutics Developing Transformative Targeted Cancer therapeutics Aravive is currently conducting clinical trials of batiraxcept (formerly AVB-500) , in combination with standard anticancer treatments in multiple indications. Completed enrollment in the AXLerate Phase 3 trial of batiraxcept in platinum-resistant ovarian cancer. Click HERE for the AXLerate Phase 3 Trial Learn More Completed enrollment in Phase 1b/2 trials of batiraxcept in clear cell renal cell carcinoma. Learn More Now enrolling patients in a Phase 1b/2 trial of batiraxcept in pancreatic adenocarcinoma. Learn More Now enrolling patients in the AXLerate Phase 3 trial of AVB-500 in platinum-resistant ovarian cancer. CLICK HERE FOR WWW.CLINICALTRIALS.GOV CLICK HERE FOR THE AXLerate PHASE 3 TRIAL Now enrolling patients in a Phase 1b/2 trial of AVB-500 in clear cell renal cell

HTTP Headers

HTTP/1.1 301 Moved Permanently
Server: nginx
Date: Sat, 30 Oct 2021 18:17:10 GMT
Content-Type: text/html
Content-Length: 162
Connection: keep-alive
Keep-Alive: timeout=20
Location: https://aravive.com/

HTTP/2 200 
server: nginx
date: Sat, 30 Oct 2021 18:17:10 GMT
content-type: text/html; charset=UTF-8
content-length: 112876
vary: Accept-Encoding
vary: Accept-Encoding
link: ; rel="https://api.w.org/"
link: ; rel="alternate"; type="application/json"
link: ; rel=shortlink
x-powered-by: WP Engine
x-cacheable: SHORT
vary: Accept-Encoding,Cookie
cache-control: max-age=600, must-revalidate
x-cache: HIT: 1
x-cache-group: normal
accept-ranges: bytes

aravive.com Whois Information

Domain Name: ARAVIVE.COM
Registry Domain ID: 2064022848_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.wildwestdomains.com
Registrar URL: http://www.wildwestdomains.com
Updated Date: 2020-10-12T18:57:30Z
Creation Date: 2016-10-06T05:57:50Z
Registry Expiry Date: 2022-10-06T05:57:50Z
Registrar: Wild West Domains, LLC
Registrar IANA ID: 440
Registrar Abuse Contact Email: abuse@wildwestdomains.com
Registrar Abuse Contact Phone: 480-624-2505
Domain Status: ok https://icann.org/epp#ok
Name Server: NS51.DOMAINCONTROL.COM
Name Server: NS52.DOMAINCONTROL.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-18T04:35:53Z <<<

aravive.com valuation and analysis